Medpace Holdings, Inc. MEDP Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $2.53B+20.0% | $2.11B+11.8% | $1.89B+29.2% | $1.46B+27.8% | ||
| $197.56M+9.6% | $180.18M+11.7% | $161.35M+22.8% | $131.4M+21.2% | ||
| $2B+20.0% | $1.66B+7.3% | $1.55B+31.1% | $1.18B+25.2% | ||
| $534.94M+19.7% | $446.87M+32.7% | $336.83M+20.9% | $278.7M+40.3% | ||
| 21.1%0.0pp | 21.2%+3.3pp | 17.9%-1.2pp | 19.1%+1.7pp | ||
| $12.78M-48.9% | $25M— | —— | -$2.91M-2,667% | ||
| $7.44M-74.4% | $29.05M— | —— | —— | ||
| $542.38M+14.0% | $475.92M+41.8% | $335.68M+18.7% | $282.86M+40.1% | ||
| $91.25M+27.6% | $71.54M+35.3% | $52.87M+41.0% | $37.49M+87.4% | ||
| $451.12M+11.6% | $404.39M+43.0% | $282.81M+15.3% | $245.37M+34.9% | ||
| 17.8%-1.3pp | 19.2%+4.2pp | 15%-1.8pp | 16.8%+0.9pp | ||
| $15.27+20.9% | $12.63+42.2% | $8.88+21.6% | $7.30+51.8% | ||
| $563.06M+18.3% | $476.12M+31.1% | $363.15M+20.6% | $301.04M+37.0% | ||
| 22.3%-0.3pp | 22.6%+3.3pp | 19.3%-1.4pp | 20.6%+1.4pp | ||
| $534.94M+19.7% | $446.87M+32.7% | $336.83M+20.9% | $278.7M+40.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Medpace Holdings, Inc.'s revenue?
- Medpace Holdings, Inc. (MEDP) generated $2.7B in revenue over the trailing twelve months, up 24.2% year over year.
- Is Medpace Holdings, Inc. profitable?
- Medpace Holdings, Inc. reported $460.4M in net income over the trailing twelve months, a 17.2% net margin.
- What is Medpace Holdings, Inc.'s earnings per share?
- Medpace Holdings, Inc.'s diluted EPS over the trailing twelve months is $15.88.
- Where does Medpace Holdings, Inc.'s income statement data come from?
- Every line is extracted from Medpace Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
